Previous close | 0.1406 |
Open | 0.1368 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's range | 0.1332 - 11.2480 |
52-week range | 0.1332 - 73.8400 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 29 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
To the annoyance of some shareholders, Pieris Pharmaceuticals, Inc. ( NASDAQ:PIRS ) shares are down a considerable 27...
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Pieris Pharmaceuticals (PIRS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.